Dopo l'orario di chiusura: 27.39

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc Borsa (MYGN) Ultime notizie

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc Borsa (MYGN) Ultime notizie

Pharmacogenomics Market Overview: Key Drivers, Restraints - openPR

28,193 Shares in Myriad Genetics, Inc. (NASDAQ:MYGN) Acquired by Hsbc Holdings PLC - MarketBeat

Myriad Genetics, Inc. (NASDAQ:MYGN) Position Reduced by D. E. Shaw & Co. Inc. - MarketBeat

Dimensional Fund Advisors LP Purchases 75,445 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN) - MarketBeat

Point72 Asset Management L.P. Grows Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN) - MarketBeat

Patent Law Trumps Policy In Myriad Cancer Gene Decision - Law360

Preventive Healthcare Technologies And Services Market Size - openPR

Profund Advisors LLC Lowers Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN) - MarketBeat

Myriad Genetics, Inc. (MYGN) stock: A year of ups and downs - US Post News

Financial Health Report: Myriad Genetics, Inc. (MYGN)’s Ratios Tell a Tale - The Dwinnex

Investing in Myriad Genetics, Inc. (MYGN): What You Must Know - Knox Daily

Myriad Genetics, Inc. (MYGN) can make a big difference with a little luck - SETE News

Mercury Systems, Inc. (NASDAQ:MRCY) Shares Sold by Blair William & Co. IL - Defense World

Blair William & Co. IL Buys 22,665 Shares of Symbotic Inc. (NASDAQ:SYM) - Defense World

Mirriad Advertising Schedules Live Interim Results Presentation - TipRanks

Sei Investments Co. Grows Position in Myriad Genetics, Inc. (NASDAQ:MYGN) - MarketBeat

Myriad Uranium Unveils Historical Data Boosting Project Potential - TipRanks

Mirriad Advertising Shares Fall After Lower Revenue, Full-Year Warning - MarketWatch

Mirriad Advertising Optimistic Despite Revenue Dip - TipRanks

King Luther Capital Management Corp Buys 13,051 Shares of Mercury Systems, Inc. (NASDAQ:MRCY) - Defense World

Federated Hermes Inc. Has $1.10 Million Holdings in The E.W. Scripps Company (NASDAQ:SSP) - Defense World

Myer Holdings Full Year 2024 Earnings: EPS: AU$0.052 (vs AU$0.074 in FY 2023) - Yahoo Finance

(MYGN) Investment Report - Stock Traders Daily

Is Myriad Genetics, Inc. (NASDAQ:MYGN) Trading At A 31% Discount? - Simply Wall St

Myriad Genetics stock upside hinges on hereditary cancer segmentMorgan Stanley - Investing.com Canada

Myriad Genetics (NASDAQ:MYGN) Earns Equal Weight Rating from Analysts at Morgan Stanley - MarketBeat

Myriad Genetics a new equal-weight at Morgan Stanley: sustained growth eyed - Seeking Alpha

Myriad Genetics stock soars to 52-week high of $29.1 - Investing.com

Myriad Genetics stock soars to 52-week high of $29.1 - Investing.com India

Here's Why Myriad Genetics (MYGN) is a Strong Momentum Stock - Yahoo Finance

Myriad Genetics to Share New Data Highlighting Genetic - GlobeNewswire

Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference - StockTitan

Myriad Genetics (NASDAQ:MYGN) Reaches New 52-Week High at $29.30 - MarketBeat

Should You Continue to Retain MYGN Stock in Your Portfolio? - Yahoo Finance

Myriad Genetics, Inc. (NASDAQ:MYGN) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Insider Sale: President and CEO Paul Diaz Sells 15,000 Shares of Myriad Genetics Inc (MYGN) - Yahoo Finance

Insider Sale: Chief Scientific Officer Dale Muzzey Sells Shares of Myriad Genetics Inc (MYGN) - Yahoo Finance

Insider Sale: President and CEO Paul Diaz Sells 15,000 Shares of Myriad Genetics Inc (MYGN) By GuruFocus - Investing.com Canada

Insider Sale: Chief Scientific Officer Dale Muzzey Sells Shares of Myriad Genetics Inc (MYGN) - GuruFocus.com

Insider Sale: President and CEO Paul Diaz Sells 15,000 Shares of Myriad Genetics Inc (MYGN) - GuruFocus.com

Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights - GlobeNewswire Inc.

Insider Sale: Chief Scientific Officer Dale Muzzey Sells Shares of Myriad Genetics Inc (MYGN) By GuruFocus - Investing.com Canada

Hereditary Testing A Game Changer for Global Finance Forecast-Myriad Genetics, Inc., CooperSurgical, Inc., Natera, Inc., Invitae Corpor – news - United States Security Bayonet ...

Myriad Genetics (NASDAQ:MYGN) Shares Down 4.9% - MarketBeat

Preventive Healthcare Technologies And Services Market Future - openPR

Myriad Genetics director sells shares worth over $270k By Investing.com - Investing.com Australia

Insider Sale: Director Heinrich Dreismann Sells Shares of Myriad Genetics Inc (MYGN) - Yahoo Finance

Myriad Genetics director sells shares worth over $270k - Investing.com

Insider Sale: Director Heinrich Dreismann Sells Shares of Myriad Genetics Inc (MYGN) By GuruFocus - Investing.com Canada

Myriad Genetics director sells shares worth over $270k By Investing.com - Investing.com Canada

Myriad Genetics director sells shares worth over $270k - Investing.com India

Myriad Genetics, Inc. (NASDAQ:MYGN) Director Sells $270,500.00 in Stock - MarketBeat

Myriad Genetics director sells shares worth over $270k By Investing.com - Investing.com UK

Natixis Advisors LLC Acquires 37,002 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN) - MarketBeat

Myriad (MYGN) Down 4.8% Since Last Earnings Report: Can It Rebound? - MSN

Myriad Genetics director Colleen Reitan sells $1.29 million in stock - Investing.com India

Myriad Genetics (NASDAQ:MYGN) Stock Price Up 4.7% - MarketBeat

How the (MYGN) price action is used to our Advantage - Stock Traders Daily

Myriad Genetics to Host Investor Event on October 9, 2024 - GlobeNewswire

Myriad (MYGN) Down 4.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Myriad Genetics to Host Investor Event on October 9, 2024 - StockTitan

Insider Selling: Myriad Genetics, Inc. (NASDAQ:MYGN) Director Sells 46,012 Shares of Stock - MarketBeat

Insider Sale: Director Colleen Reitan Sells Shares of Myriad Genetics Inc (MYGN) - Yahoo Finance

Insider Sale: Director Colleen Reitan Sells Shares of Myriad Genetics Inc (MYGN) By GuruFocus - Investing.com Canada

Myriad Genetics halts part of GeneSight study - Investing.com

Myriad Genetics director Colleen Reitan sells $1.29 million in stock - Investing.com

Myriad Genetics director Colleen Reitan sells $1.29 million in stock By Investing.com - Investing.com Canada

Myriad Genetics (NASDAQ:MYGN) Stock Price Down 3.2% - MarketBeat

Myriad Genetics halts part of GeneSight study By Investing.com - Investing.com Canada

New Partnerships to Aid Myriad Genetics Stock Amid Macro Issues - Yahoo Finance

Simile a MYGN